A

Ascendis Pharma A/S

D
ASND
USD
-2.7
(-2.089%)
Market Closed
6,028.00
Volume
-8.31344
EPS
-
Div Yield
-13.592674
P/E
7,548,762,802.35
Market Cap
Today
-1.2562%
1 Week
2.962%
1 Month
-9.075%
6 Months
-6.947%
12 Months
31.494%
Year To Date
0.588%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
T
TKR
-2.2
(-2.7778%)
USD
C
CF
1.56
(1.8777%)
USD
AMP
AMP
-19.79
(-3.4863%)
USD
O
OCFC
-0.84
(-3.9943%)
USD
L
LSXMA
(%)
USD
A
AAL
-0.335
(-2.4014%)
USD
ETN
ETN
1.3
(0.3619%)
USD
B
BFS
-0.06
(-0.1461%)
USD

Title:
Ascendis Pharma A/S

Sector:
Healthcare
Industry:
Biotechnology
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.
Do you need help or have a question?
Contact Us